Skip to content
lifestyle.chroniccities.us
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
SQ Innovation
Interim Real-World Results Show At-Home Subcutaneous Furosemide Can Effectively Treat Worsening Heart Failure in Patients at Imminent Risk for Hospital Admission
October 12, 2026
New HCPCS Billing Code Enables Medicare Benefit Billing of Lasix® ONYU When Furnished Incident to a Physician’s Service
September 2, 2026
Trial Results Support At-Home Treatment of Edema in Heart Failure with Subcutaneous Furosemide as an Effective and Safe Alternative to Inpatient Hospital Care
May 11, 2026
Lasix® ONYU[1] Achieves CE Marking under EU Medical Device Regulation, Reaching a Critical Milestone Toward International Market Authorization; European Medicines Agency Confirms Eligibility for Centralized Procedure Review Based on Technical Innovation
April 28, 2026
Lasix® ONYU Now Available from Walmart Specialty Pharmacy for Home Delivery
April 21, 2026
SQ Innovation and FIS Announce Strategic Supply Agreement for Furosemide API
April 15, 2026